Cyclacel Pharmaceuticals, Inc. - Common Stock (NQ:CYCC)

6.365 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 11, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cyclacel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

April 30, 2024

From Cyclacel

Via GlobeNewswire

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

Earnings Outlook For Cyclacel Pharmaceuticals ↗

March 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 29, 2024

Via Benzinga

Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket ↗

April 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 25, 2024

Via Benzinga

Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 11, 2024

Via Benzinga

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

April 01, 2024

From Cyclacel

Via GlobeNewswire

CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023 ↗

March 19, 2024

CYCC stock results show that Cyclacel Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

March 19, 2024

From Cyclacel

Via GlobeNewswire

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results

March 13, 2024

From Cyclacel

Via GlobeNewswire

Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

March 07, 2024

Data support ongoing development program of novel CDK2/9 inhibitor fadraciclib in patients with solid tumors and lymphoma

From Cyclacel

Via GlobeNewswire

Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit

March 06, 2024

From Cyclacel

Via GlobeNewswire

Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference

February 20, 2024

From Cyclacel

Via GlobeNewswire

Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer

January 30, 2024

From Cyclacel

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 12, 2024

Via Benzinga

RKLB Stock Alert: The $500 Million Reason Rocket Lab Is Moving Today ↗

January 09, 2024

Rocket Lab stock is on the move Tuesday as investors in RKLB react to a new $515 million contract with Space Development Agency.

Via InvestorPlace

Unity Layoffs 2024: What to Know About the Latest U Job Cuts ↗

January 09, 2024

Unity layoffs are on the way as the video game software company reveals plans to cut 1,800 jobs to focus on its core business.

Via InvestorPlace

Topics Workforce

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today? ↗

January 09, 2024

Cyclacel Pharmaceuticals stock is slipping on Tuesday after shares of CYCC rallied on Monday alongside it regaining Nasdaq compliance.

Via InvestorPlace

Why Juniper Networks Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2024

Shares of Juniper Networks, Inc. (NYSE: JNPR) rose sharply in pre-market trading on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 09, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 09, 2024

Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!

Via InvestorPlace

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

January 08, 2024

From Cyclacel

Via GlobeNewswire

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket ↗

January 08, 2024

Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th....

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.